The Blood Cancers/Transplant and Cellular Therapies Program at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center is one of the nation’s leading programs for the treatment of hematologic malignancies. With a focus on excellence and compassion, our physicians and staff manage patients at all stages of their care.
Our program is accredited by the Foundation for the Accreditation of Cellular Therapy, which recognizes top-quality patient care. We also have been deemed a national center of excellence by all major national health insurance carriers.
At Simmons Cancer Center, we offer CAR T-cell therapy for the treatment of leukemia, lymphoma, and myeloma. We are one of just nine U.S. hospitals participating in the most advanced phases of clinical trials of CAR T-cell therapy for multiple myeloma.
We are an approved site for Yescarta, Kymriah, and Breyanzi immunotherapies for the treatment of lymphoma, Tecartus and Kymriah immunotherapies for the treatment of leukemia, and Abecma immunotherapy for the treatment of myeloma.
Contact Phone: 214-645-4673